Medivir AB announced that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2022. According to an AGM resolution, the Nomination Committee 2021-2022 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2021 and the Chairman of the Board. Work on composing the Nomination Committee is now completed, and this year's Nomination Committee consists of: Karl Tobieson (Chairman), appointed by Linc AB; Jan S?rlvik, appointed by Nordea Fonder; Anders Hallberg, appointed by HealthInvest Partners; and Uli Hacksell, Chairman of the Board, Medivir AB.